(HLT) Hilton Worldwide Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US43300A2033
Stock: Hotel Rooms, Timeshares
Total Rating 59
Risk 41
Buy Signal -0.44
| Risk 5d forecast | |
|---|---|
| Volatility | 22.1% |
| Relative Tail Risk | -1.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | 1.90 |
| Character TTM | |
|---|---|
| Beta | 0.912 |
| Beta Downside | 0.953 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.35% |
| CAGR/Max DD | 1.13 |
EPS (Earnings per Share)
Revenue
Description: HLT Hilton Worldwide Holdings January 28, 2026
Hilton Worldwide Holdings Inc. (NYSE: HLT) is a global hospitality firm that manages, franchises, owns, and leases hotels and resorts across 12 brands ranging from luxury (Waldorf Astoria, Conrad) to economy (Hampton, Tru). Its operations are split between a Management & Franchise segment, which generates fee-based revenue, and an Ownership segment, which contributes earnings from property assets. The company’s footprint spans North, Central, and South America, Europe, the Middle East, Africa, and the Asia-Pacific.
As of FY 2023, Hilton reported $9.5 billion in total revenue, with RevPAR (Revenue per Available Room) up 12% YoY in its core North American market, reflecting strong leisure travel demand. Occupancy rates in the Asia-Pacific region reached 71% in Q4 2024, the highest quarterly level since 2019, driven by easing visa restrictions and robust inbound tourism. The firm’s pipeline includes over 1,200 new rooms slated for opening by 2026, a figure that aligns with the industry-wide supply deficit projected to keep average daily rates (ADR) above inflationary pressures.
For a deeper, data-rich assessment of Hilton’s valuation dynamics, you may find ValueRay’s analytical tools useful for further research.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 1.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 6.13 > 0.02 and ΔFCF/TA 603.1 > 1.0 |
| NWC/Revenue: -38.36% < 20% (prev -12.78%; Δ -25.58% < -1%) |
| CFO/TA 6.58 > 3% & CFO 2.51b > Net Income 1.46b |
| Net Debt (970.0m) to EBITDA (2.87b): 0.34 < 3 |
| Current Ratio: 0.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.0m) vs 12m ago -3.25% < -2% |
| Gross Margin: 41.15% > 18% (prev 0.27%; Δ 4088 % > 0.5%) |
| Asset Turnover: 142.4% > 50% (prev 67.63%; Δ 74.82% > 0%) |
| Interest Coverage Ratio: 4.34 > 6 (EBITDA TTM 2.87b / Interest Expense TTM 620.0m) |
Altman Z'' -15.00
| A: -12.12 (Total Current Assets 80.0m - Total Current Liabilities 4.70b) / Total Assets 381.0m |
| B: -4.65 (Retained Earnings -1.77b / Total Assets 381.0m) |
| C: 0.32 (EBIT TTM 2.69b / Avg Total Assets 8.45b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 21.53b) |
| Altman-Z'' Score: -92.52 = D |
Beneish M -4.00
| DSRI: 0.01 (Receivables 17.0m/1.58b, Revenue 12.04b/11.17b) |
| GMI: 0.67 (GM 41.15% / 27.41%) |
| AQI: 0.06 (AQ_t 0.05 / AQ_t-1 0.74) |
| SGI: 1.08 (Revenue 12.04b / 11.17b) |
| TATA: -2.76 (NI 1.46b - CFO 2.51b) / TA 381.0m) |
| Beneish M-Score: -7.48 (Cap -4..+1) = AAA |
What is the price of HLT shares?
As of February 16, 2026, the stock is trading at USD 314.62 with a total of 2,384,741 shares traded.
Over the past week, the price has changed by +0.19%, over one month by +4.23%, over three months by +18.32% and over the past year by +17.28%.
Over the past week, the price has changed by +0.19%, over one month by +4.23%, over three months by +18.32% and over the past year by +17.28%.
Is HLT a buy, sell or hold?
Hilton Worldwide Holdings has received a consensus analysts rating of 3.62.
Therefor, it is recommend to hold HLT.
- StrongBuy: 7
- Buy: 3
- Hold: 15
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 313.9 | -0.2% |
| Analysts Target Price | 313.9 | -0.2% |
| ValueRay Target Price | 392.9 | 24.9% |
HLT Fundamental Data Overview February 14, 2026
P/E Trailing = 52.6422
P/E Forward = 35.2113
P/S = 15.1158
P/EG = 1.812
Revenue TTM = 12.04b USD
EBIT TTM = 2.69b USD
EBITDA TTM = 2.87b USD
Long Term Debt = 11.60b USD (from longTermDebt, two quarters ago)
Short Term Debt = 35.0m USD (from shortTermDebt, two quarters ago)
Debt = 12.35b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 970.0m USD (from netDebt column, last quarter)
Enterprise Value = 87.17b USD (74.88b + Debt 12.35b - CCE 63.0m)
Interest Coverage Ratio = 4.34 (Ebit TTM 2.69b / Interest Expense TTM 620.0m)
EV/FCF = 37.30x (Enterprise Value 87.17b / FCF TTM 2.34b)
FCF Yield = 2.68% (FCF TTM 2.34b / Enterprise Value 87.17b)
FCF Margin = 19.41% (FCF TTM 2.34b / Revenue TTM 12.04b)
Net Margin = 12.10% (Net Income TTM 1.46b / Revenue TTM 12.04b)
Gross Margin = 41.15% ((Revenue TTM 12.04b - Cost of Revenue TTM 7.08b) / Revenue TTM)
Gross Margin QoQ = 76.45% (prev 30.16%)
Tobins Q-Ratio = 228.8 (set to none) (Enterprise Value 87.17b / Total Assets 381.0m)
Interest Expense / Debt = 1.34% (Interest Expense 165.0m / Debt 12.35b)
Taxrate = 31.47% (135.0m / 429.0m)
NOPAT = 1.85b (EBIT 2.69b * (1 - 31.47%))
Current Ratio = 0.02 (Total Current Assets 80.0m / Total Current Liabilities 4.70b)
Debt / Equity = -2.50 (negative equity) (Debt 12.35b / totalStockholderEquity, two quarters ago -4.93b)
Debt / EBITDA = 0.34 (Net Debt 970.0m / EBITDA 2.87b)
Debt / FCF = 0.42 (Net Debt 970.0m / FCF TTM 2.34b)
Total Stockholder Equity = -4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.24% (Net Income 1.46b / Total Assets 381.0m)
RoE = -33.06% (negative equity) (Net Income TTM 1.46b / Total Stockholder Equity -4.41b)
RoCE = 37.42% (EBIT 2.69b / Capital Employed (Equity -4.41b + L.T.Debt 11.60b))
RoIC = 27.91% (NOPAT 1.85b / Invested Capital 6.61b)
WACC = 8.10% (E(74.88b)/V(87.23b) * Re(9.28%) + D(12.35b)/V(87.23b) * Rd(1.34%) * (1-Tc(0.31)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.95%
[DCF Debug] Terminal Value 80.20% ; FCFF base≈2.08b ; Y1≈2.44b ; Y5≈3.67b
Fair Price DCF = 263.7 (EV 61.44b - Net Debt 970.0m = Equity 60.47b / Shares 229.3m; r=8.10% [WACC]; 5y FCF grow 18.04% → 2.90% )
EPS Correlation: 73.03 | EPS CAGR: 33.19% | SUE: 0.33 | # QB: 0
Revenue Correlation: 86.76 | Revenue CAGR: 16.86% | SUE: 2.32 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.92 | Chg30d=+0.079 | Revisions Net=-3 | Analysts=15
EPS current Year (2026-12-31): EPS=9.06 | Chg30d=-0.080 | Revisions Net=+2 | Growth EPS=+11.7% | Growth Revenue=+7.8%
EPS next Year (2027-12-31): EPS=10.46 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=+15.4% | Growth Revenue=+8.1%
P/E Forward = 35.2113
P/S = 15.1158
P/EG = 1.812
Revenue TTM = 12.04b USD
EBIT TTM = 2.69b USD
EBITDA TTM = 2.87b USD
Long Term Debt = 11.60b USD (from longTermDebt, two quarters ago)
Short Term Debt = 35.0m USD (from shortTermDebt, two quarters ago)
Debt = 12.35b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 970.0m USD (from netDebt column, last quarter)
Enterprise Value = 87.17b USD (74.88b + Debt 12.35b - CCE 63.0m)
Interest Coverage Ratio = 4.34 (Ebit TTM 2.69b / Interest Expense TTM 620.0m)
EV/FCF = 37.30x (Enterprise Value 87.17b / FCF TTM 2.34b)
FCF Yield = 2.68% (FCF TTM 2.34b / Enterprise Value 87.17b)
FCF Margin = 19.41% (FCF TTM 2.34b / Revenue TTM 12.04b)
Net Margin = 12.10% (Net Income TTM 1.46b / Revenue TTM 12.04b)
Gross Margin = 41.15% ((Revenue TTM 12.04b - Cost of Revenue TTM 7.08b) / Revenue TTM)
Gross Margin QoQ = 76.45% (prev 30.16%)
Tobins Q-Ratio = 228.8 (set to none) (Enterprise Value 87.17b / Total Assets 381.0m)
Interest Expense / Debt = 1.34% (Interest Expense 165.0m / Debt 12.35b)
Taxrate = 31.47% (135.0m / 429.0m)
NOPAT = 1.85b (EBIT 2.69b * (1 - 31.47%))
Current Ratio = 0.02 (Total Current Assets 80.0m / Total Current Liabilities 4.70b)
Debt / Equity = -2.50 (negative equity) (Debt 12.35b / totalStockholderEquity, two quarters ago -4.93b)
Debt / EBITDA = 0.34 (Net Debt 970.0m / EBITDA 2.87b)
Debt / FCF = 0.42 (Net Debt 970.0m / FCF TTM 2.34b)
Total Stockholder Equity = -4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.24% (Net Income 1.46b / Total Assets 381.0m)
RoE = -33.06% (negative equity) (Net Income TTM 1.46b / Total Stockholder Equity -4.41b)
RoCE = 37.42% (EBIT 2.69b / Capital Employed (Equity -4.41b + L.T.Debt 11.60b))
RoIC = 27.91% (NOPAT 1.85b / Invested Capital 6.61b)
WACC = 8.10% (E(74.88b)/V(87.23b) * Re(9.28%) + D(12.35b)/V(87.23b) * Rd(1.34%) * (1-Tc(0.31)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.95%
[DCF Debug] Terminal Value 80.20% ; FCFF base≈2.08b ; Y1≈2.44b ; Y5≈3.67b
Fair Price DCF = 263.7 (EV 61.44b - Net Debt 970.0m = Equity 60.47b / Shares 229.3m; r=8.10% [WACC]; 5y FCF grow 18.04% → 2.90% )
EPS Correlation: 73.03 | EPS CAGR: 33.19% | SUE: 0.33 | # QB: 0
Revenue Correlation: 86.76 | Revenue CAGR: 16.86% | SUE: 2.32 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.92 | Chg30d=+0.079 | Revisions Net=-3 | Analysts=15
EPS current Year (2026-12-31): EPS=9.06 | Chg30d=-0.080 | Revisions Net=+2 | Growth EPS=+11.7% | Growth Revenue=+7.8%
EPS next Year (2027-12-31): EPS=10.46 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=+15.4% | Growth Revenue=+8.1%